Pharmacy Technician (Fixed Term) – Prison Health

Practice Plus Group Holdings Limited; Park Village; Sur place; GBP 23 000 - 27 000; Plein temps

Avantages offerts par ce poste

Free Parking

Gym Access

Training & Development opportunities

Discounts on shopping & leisure

Résumé du poste

Practice Plus Group is recruiting a Pharmacy Technician for the Primary Care team at HMP Oakwood in Wolverhampton. This fixed-term contract runs until April 2027, supporting a large prison site with a dedicated pharmacy team and multiple dispensaries.

You will maintain accurate patient records, follow SOPs, and ensure timely medicines administration while promoting cost-effective prescribing within our medicines policy. Collaboration with MDT is essential.

Qualifications

• Hold NVQ Level 3, BTEC, or equivalent qualifications and have current registration with the General Pharmaceutical Council (GPHC).
• Post-qualification experience working within a pharmacy environment and multi-disciplinary team.
• Ability to work unsupervised whilst following policy and procedures.

Responsabilités

• Maintain patient medical records to the agreed standard and ensure SOPs are followed.
• Ensure timely administration of medicines and cost‑effective prescribing as defined in the medicines policy.
• Communicate complex or sensitive information with empathy to patients.
• Share information on medicines, medicines optimisation, regimes and legislation with the MDT.

Connaissances

GPHC Registration

Post-qualification pharmacy experience

Ability to work unsupervised

Communication skills

Formation

NVQ Level 3 / BTEC or equivalent

Description du poste

Practice Plus Group is recruiting a Pharmacy Technician for the Primary Care team at HMP Oakwood in Wolverhampton. This fixed-term contract runs until April 2027, supporting a large prison site with a dedicated pharmacy team and multiple dispensaries.

You will maintain accurate patient records, follow SOPs, and ensure timely medicines administration while promoting cost-effective prescribing within our medicines policy. Collaboration with MDT is essential.